Laurel A. Menapace/LinkedIn
Aug 2, 2026, 09:04
Laurel A. Menapace: Investing in the Next Generation of Hematology Leaders
Laurel A. Menapace, Former Senior Clinical Research Director of Rare Blood Disorders, Fitusiran Development Program at Sanofi, shared a post on LinkedIn:
“Thoroughly enjoyed participating in ISTH’s ECC Networking with Industry Session.
Some of the best career advice I’ve received has come from people willing to share their experiences openly.
I’m grateful for the opportunity to pay that forward and discuss career paths, clinical development, industry partnerships, and the many ways we can continue advancing therapies for patients.
Building the future of hematology requires more than great science—it requires investing in the people who will lead it.”
Stay updated with Hemostasis Today.
-
Sep 20, 2026, 09:51Ceasovschih Alexandr: A Closer Look at Lipid Disorders in CKM Syndrome
-
Sep 20, 2026, 09:05World Stroke Academy: Can Adjunct IAT Improve Tissue Reperfusion?
-
Sep 20, 2026, 06:46Neeraj Songara: From Donated Blood to Engineered Therapeutics
-
Sep 20, 2026, 06:24Louise St. Germain Bannon: Improving Awareness and Care for Women Across the Lifespan
-
Sep 20, 2026, 05:17Maxime Dely: When ABO Compatibility Isn’t Enough for Safe Transfusion
-
Sep 20, 2026, 04:54William Aird: What Does a Complete History and Physical Really Mean?
-
Sep 20, 2026, 04:34Hons Saurabh Kaushik: Why Uncontrolled LDL Can Be Harmful
-
Sep 20, 2026, 03:58Salih Ehsan: The Complexities of HbF and HbA2
-
Sep 20, 2026, 03:22The Voices of People Living With Bleeding Disorders – EHC